D'Orazio & Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,092
Closed -$200K 149
2022
Q3
$200K Buy
+2,092
New +$207K 0.06% 120
2021
Q4
Sell
-638
Closed -$54K 239
2021
Q3
$54K Buy
638
+203
+47% +$17K 0.01% 191
2021
Q2
$36K Buy
+435
New +$35.6K 0.01% 196
2019
Q2
Sell
-70
Closed -$4K 336
2019
Q1
$4K Buy
+70
New +$4.32K ﹤0.01% 285
2017
Q3
Sell
-1,700
Closed -$137K 278
2017
Q2
$137K Buy
1,700
+140
+9% +$11.1K 0.05% 63
2017
Q1
$122K Hold
1,560
0.05% 68
2016
Q4
$123K Buy
1,560
+400
+34% +$32.4K 0.05% 65
2016
Q3
$103K Hold
1,160
0.04% 75
2016
Q2
$111K Buy
1,160
+100
+9% +$9.97K 0.04% 74
2016
Q1
$109K Buy
1,060
+620
+141% +$60.3K 0.05% 75
2015
Q4
$43K Buy
440
+300
+214% +$29.4K 0.02% 108
2015
Q3
$14K Sell
140
-500
-78% -$52.6K 0.01% 169
2015
Q2
$68K Hold
640
0.05% 76
2015
Q1
$66K Hold
640
0.05% 78
2014
Q4
$62K Sell
640
-10
-2% -$881 0.04% 78
2014
Q3
$52K Hold
650
0.04% 82
2014
Q2
$49K Hold
650
0.04% 88
2014
Q1
$49K Hold
650
0.04% 80
2013
Q4
$47K Buy
+650
New +$41.8K 0.04% 73

Other funds holding CVS

D'Orazio & Associates's CVS Position: Q4 2022 in Review

D'Orazio & Associates sold out of CVS Health (CVS) in Q4 2022, closing a stake of 2,092 shares — an estimated $200K sold.

D'Orazio & Associates first reported a position in CVS in Q4 2013 and held it in 19 quarters. The position peaked at $200K in Q3 2022. 2,405 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • D'Orazio & Associates reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • D'Orazio & Associates sold 2,092 CVS Health shares in Q4 2022, an estimated $200K.
  • D'Orazio & Associates first reported a position in CVS Health in Q4 2013 and held it in 19 quarters.
  • D'Orazio & Associates's CVS Health position peaked at $200K in Q3 2022.
  • 2,405 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on D'Orazio & Associates's 13F filing for Q4 2022, filed 26 Jan 2023.